Morgan Stanley Reiterates Equal-Weight on Accolade, Maintains $14 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser has reiterated an Equal-Weight rating on Accolade (NASDAQ:ACCD) and maintained a $14 price target.
June 30, 2023 | 1:03 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Morgan Stanley has reiterated an Equal-Weight rating on Accolade and maintained a $14 price target.
The news is directly about Accolade and its rating by Morgan Stanley. The Equal-Weight rating suggests that the stock is expected to perform in line with the market or other stocks in its sector. The maintained price target indicates that the analyst's view on the stock has not changed. This could have a neutral impact on the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100